Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for lung cancer.

Eric B Haura1, Eduardo Sotomayor, Scott J Antonia

  • 1Thoracic Oncology Program, The H. Lee Moffitt Cancer Center and Research Institute. MRC3 East, Room 3056, 12902 Magnolia Drive, Tampa, FL 33612-9497, USA. haura@moffitt.usf.edu

Molecular Biotechnology
|October 4, 2003
PubMed
Summary

Gene therapy offers new lung cancer treatment strategies by targeting molecular changes. While challenges remain in precise delivery, these approaches advance understanding and potential therapies for lung cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting GSTZ1 Sensitizes KRASG12C-Mutant Lung Cancer Cells by Overcoming Glutathione and Glycolysis Pathway Rewiring.

Cancer research communications·2026
Same author

Pre-clinical efficacy of trastuzumab deruxtecan plus sotorasib in <i>KRAS<sup>G12C</sup></i> -mutant non-small cell lung cancer and exploratory HER2 profiling in human tumors.

Translational lung cancer research·2026
Same author

Does artificial intelligence need companionship to assist in drug discovery? The Kirsten rat sarcoma virus study.

BJR artificial intelligence·2026
Same author

Integrating computational chemistry and machine learning to predict KRAS mutation-induced resistance.

bioRxiv : the preprint server for biology·2026
Same author

Erratum: Using Bayesian Networks to Predict Urgent Care Visits in Patients Receiving Systemic Therapy for Non-Small Cell Lung Cancer.

JCO clinical cancer informatics·2026
Same author

Alirocumab plus cemiplimab in advanced immuno-refractory metastatic non-small cell lung cancer: an ongoing multi-center phase II study.

Future oncology (London, England)·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Lung cancer remains a leading cause of cancer-related death.
  • Current treatments like chemotherapy have limitations.
  • Understanding molecular pathogenesis is key to novel therapies.

Purpose of the Study:

  • To review gene therapy techniques for targeting molecular alterations in lung cancer.
  • To discuss the potential of gene therapy in lung cancer treatment.

Main Methods:

  • Review of gene therapy strategies targeting oncogenes and tumor suppressor genes.
  • Discussion of suicide gene introduction, gene replacement, oncogene inactivation, and immunotherapy.

Main Results:

  • Gene therapy approaches aim to exploit molecular alterations in lung cancer.

Related Experiment Videos

  • Techniques include introducing suicide genes, replacing tumor suppressor genes, inactivating oncogenes, and immunotherapy.

    • Conclusions:

    • Targeting molecular alterations via gene therapy shows promise for lung cancer treatment.
    • Specific targeting of tumor cells remains a significant challenge.
    • Further research is expected to yield valuable clinical data for lung cancer therapy advancement.